Related Experiment Videos
Left ventricular function at rest and during Raynaud's phenomenon in patients with scleroderma
American Heart Journal
|December 1, 1984
Summary
Scleroderma patients with heart failure symptoms often have normal systolic function. Echocardiography is crucial for assessing left ventricular function, as clinical signs and chest X-rays are unreliable indicators in scleroderma.
Area of Science:
- Cardiology
- Rheumatology
- Internal Medicine
Background:
- Scleroderma (systemic sclerosis) can affect the heart, leading to symptoms of congestive heart failure.
- Accurate assessment of left ventricular function is critical for appropriate patient management.
Purpose of the Study:
- To evaluate left ventricular systolic and diastolic function in scleroderma patients presenting with heart failure symptoms.
- To determine the utility of clinical signs and chest radiography in assessing cardiac function in this population.
Main Methods:
- M-mode and two-dimensional echocardiography were performed on 10 scleroderma patients.
- Cold pressor testing was used to assess cardiovascular response.
- Left ventricular ejection fraction (LVEF) was analyzed.
Main Results:
- All patients exhibited normal to increased left ventricular systolic function via echocardiography.
- Chest radiographs were not reliable indicators of systolic function; some patients showed congestion despite normal LVEF.
- Left ventricular hypertrophy correlated with worse functional class and increased pulmonary congestion.
- Cold pressor testing induced peripheral Raynaud's phenomenon but did not significantly impair LVEF in most patients.
Conclusions:
- Clinical symptoms and chest X-rays are poor indicators of impaired left ventricular systolic function in scleroderma.
- Diminished diastolic compliance, not systolic dysfunction, may cause heart failure symptoms in some scleroderma patients with hypertrophy.
- Echocardiography or angiography is recommended for evaluating left ventricular systolic function before initiating treatment with inotropic agents.